Literature DB >> 8674241

Release of sIL-2R alpha from and activation of native human peripheral blood mononuclear cells by recombinant IL-15.

S Treiber-Held1, D M Stewart, H A Barraclough, C C Kurman, D L Nelson.   

Abstract

The cytokine interleukin (IL)-15 shares several activities with IL-2. Both cytokines induced expression of cell-surface IL-2R alpha (CD25) on freshly isolated human peripheral blood mononuclear cells (PBMC) in the absence of other exogenous stimuli. They also stimulated the release of soluble IL-2R alpha and induced proliferation of these cells in 1-week cultures in a time- and dose-dependent manner. Recombinant IL-7 could also induce the expression of CD25, although sIL-2R alpha was released at only low levels. In monocyte-depleted PBMC the sIL-2R alpha release was minimal. When isolated T cells or non-T cells were stimulated by rIL-15 or rIL-2, cell surface CD25 was expressed, but released sIL-2R alpha was undetectable. On stimulation with rIL-15, more than 80% of all natural killer cells expressed CD25 and more CD8br+ lymphocytes were positive for CD25 compared to stimulation by rIL-2. These results may be clinically relevant because several diseases are associated with high serum levels of sIL-2R alpha which may he not only due to IL-2 but also due to IL-15 stimulation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8674241     DOI: 10.1006/clin.1996.0095

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  2 in total

1.  Changes in natural killer cells, the CD57CD8 subset, and related cytokines in healthy aging.

Authors:  S E McNerlan; I M Rea; H D Alexander; T C Morris
Journal:  J Clin Immunol       Date:  1998-01       Impact factor: 8.317

2.  Requirement of dual stimulation by homologous recombinant IL-2 and recombinant IL-12 for the in vitro production of interferon gamma by canine peripheral blood mononuclear cells.

Authors:  Andrea Mendes Pereira; Cristiane Garboggini Melo de Pinheiro; Lenita Ramires Dos Santos; Naiara Carvalho Teixeira; Yung-Fu Chang; Lain Carlos Pontes-de-Carvalho; Geraldo Gileno de Sá Oliveira
Journal:  BMC Res Notes       Date:  2014-07-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.